Inozyme Pharma, Inc.
INZYDelisted Jul 1, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001693011
Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Inozyme Pharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- −1 vs. Q3 2021
- Shares held
- 17.3M
- −155.8K (−0.9%) vs. Q3 2021
- Total value
- $118.2M
- −$84.5M (−41.7%) vs. Q3 2021
- New holders
- 8
- 17 more added
- Sold out
- 9
- 14 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INZY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 87 | $202.3M |
| Q1 2025 | 97 | $42.5M |
| Q4 2024 | 105 | $145.1M |
| Q3 2024 | 89 | $285.5M |
| Q2 2024 | 90 | $240.1M |
| Q1 2024 | 89 | $382.0M |
| Q4 2023 | 80 | $213.3M |
| Q3 2023 | 77 | $204.6M |
| Q2 2023 | 74 | $190.3M |
| Q1 2023 | 50 | $183.4M |
| Q4 2022 | 37 | $30.4M |
| Q3 2022 | 39 | $82.7M |
| Q2 2022 | 47 | $149.4M |
| Q1 2022 | 50 | $71.2M |
| Q4 2021 | 51 | $118.2M |
| Q3 2021 | 52 | $202.7M |
| Q2 2021 | 50 | $337.1M |
| Q1 2021 | 55 | $379.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Inozyme Pharma, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 2,444,379 | $16.7M | 0.34% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,344,786 | $16.0M | 0.34% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,028,308 | $13.8M | 0.89% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,599,028 | $10.9M | 0.02% | +131,200+8.9% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,591,154 | $10.9M | 4.54% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 1,013,216 | $6.91M | 0.13% | +26,816+2.7% | Added |
| CHI Advisors LLC | 892,057 | $6.08M | 2.02% | −28,207−3.1% | Reduced |
| Rock Springs Capital Management LP | 868,466 | $5.92M | 0.14% | +18,451+2.2% | Added |
| BlackRock Inc. | 836,998 | $5.71M | 0.00% | −63,721−7.1% | Reduced |
| FMR LLC | 609,380 | $4.16M | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 526,600 | $3.59M | 0.05% | +232,600+79.1% | Added |
| Vanguard Group Inc | 488,719 | $3.33M | 0.00% | −122,466−20.0% | Reduced |
| JPMorgan Chase & Co | 324,387 | $2.21M | 0.00% | −7,504−2.3% | Reduced |
| MPM Oncology Impact Management LP | 302,615 | $2.06M | 0.38% | −18,109−5.6% | Reduced |
| State Street Corp | 187,102 | $1.28M | 0.00% | −1,165−0.6% | Reduced |
| Geode Capital Management, LLC | 184,019 | $1.25M | 0.00% | −14,605−7.4% | Reduced |
| Janus Henderson Group PLC | 125,153 | $857.0K | 0.00% | +125,153 | New |
| Northern Trust Corp | 120,762 | $823.0K | 0.00% | +4,661+4.0% | Added |
| Caas Capital Management LP | 113,091 | $771.0K | 0.07% | −22,307−16.5% | Reduced |
| Baker Bros. Advisors LP | 106,999 | $730.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 106,978 | $729.0K | 0.00% | +12,512+13.2% | Added |
| Jacobs Levy Equity Management, Inc | 88,921 | $606.0K | 0.00% | +67,884+322.7% | Added |
| Bridgeway Capital Management, LLC | 77,400 | $528.0K | 0.01% | +77,400 | New |
| Bank of New York Mellon Corp | 41,196 | $281.0K | 0.00% | +778+1.9% | Added |
| Nuveen Asset Management, LLC | 42,261 | $251.0K | 0.00% | −5,401−11.3% | Reduced |
| Charles Schwab Investment Management Inc | 36,427 | $249.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 36,033 | $247.0K | 0.00% | +2,625+7.9% | Added |
| Millennium Management LLC | 19,952 | $136.0K | 0.00% | +8,888+80.3% | Added |
| Morgan Stanley | 19,440 | $133.0K | 0.00% | +1,446+8.0% | Added |
| Overbrook Management Corp | 16,726 | $114.0K | 0.02% | 00.0% | Unchanged |
| Walleye Capital LLC | 15,588 | $106.0K | 0.00% | +15,588 | New |
| Laurion Capital Management LP | 13,390 | $91.0K | 0.00% | −57,310−81.1% | Reduced |
| Goldman Sachs Group Inc | 13,239 | $90.0K | 0.00% | −3,326−20.1% | Reduced |
| Rhumbline Advisers | 13,064 | $89.0K | 0.00% | −398−3.0% | Reduced |
| Ergoteles LLC | 12,200 | $83.0K | 0.00% | +12,200 | New |
| Bank of America Corp | 11,853 | $81.0K | 0.00% | +11,566+4,030.0% | Added |
| Deutsche Bank AG | 8,728 | $60.0K | 0.00% | +452+5.5% | Added |
| Wells Fargo & Company | 7,983 | $54.0K | 0.00% | +7,935+16,531.3% | Added |
| California State Teachers Retirement System | 7,730 | $53.0K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 7,647 | $52.0K | 0.00% | −228−2.9% | Reduced |
| UBS Group AG | 7,228 | $49.0K | 0.00% | +7,228 | New |
| New York State Common Retirement Fund | 3,834 | $26.0K | 0.00% | −6,619−63.3% | Reduced |
| Acadian Asset Management LLC | 3,676 | $25.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 3,664 | $25.0K | 0.00% | +560+18.0% | Added |
| Royal Bank of Canada | 3,011 | $20.0K | 0.00% | +1,170+63.6% | Added |
| Tower Research Capital LLC (TRC) | 1,402 | $10.0K | 0.00% | +597+74.2% | Added |
| Legal & General Group Plc | 1,147 | $8.00K | 0.00% | 00.0% | Unchanged |
| Amplius Wealth Advisors, LLC | 1,000 | $6.00K | 0.00% | +1,000 | New |
| Ameritas Investment Partners, Inc. | 692 | $5.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 121 | $1.00K | 0.00% | +121 | New |
| Toronto Dominion Bank | 2 | $0 | 0.00% | +2 | New |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −364,600−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −115,516−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −65,781−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,611−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −7,991−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −540−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −44−100.0% | Sold out |